| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 13.12 | 171.6% | 1697.3% |
| Total Income | 13.12 | 171.6% | 1697.3% |
| Expenditure | 69.55 | 1.6% | 42.4% |
| PBT | -55.79 | 5.5% | 35.4% |
| Net Profit | -55.79 | 5.5% | 35.4% |
| OPM | — | ||
| NPM | — | ||
| EPS | -0.16 | 5.9% | 6.7% |
Nuvation Bio Inc. Reports Q3 2025 Financial Results
04 May 2026 · 4 May, 8:19 am
Summary
Nuvation Bio Inc. announced its financial results for the quarter ended September 30, 2025, in a press release issued on November 3, 2025. The press release is included as Exhibit 99.1 to the Form 8-K. Further details regarding the financial results can be found in the exhibit.
Key Highlights
- 1
Nuvation Bio Inc. announced its financial results for the quarter ended September 30, 2025.
- 2
A press release detailing the financial results was issued on November 3, 2025.
- 3
The press release is furnished as Exhibit 99.1 to the Form 8-K.
Informational and educational content only. Not investment advice.